CBD for the Treatment of Alcohol Use Disorder

Summary

This is a double-blind, placebo-controlled, parallel group study designed to assess the efficacy of full spectrum cannabidiol (CBD) and broad spectrum CBD, compared to a placebo control (PC), to reduce drinking in participants with moderate alcohol use disorder according to the DSM-V. If eligible for the study, subjects will be randomized to receive one of the conditions for 8 weeks.

Timeline

Start

2021-08-30

Primary completion

2023-05-31

Completion

2023-05-31

Publications

• Mueller RL, Hooper JF, Ellingson JM, Olsavsky AK, Rzasa-Lynn R, Bryan AD, Bidwell LC, Hutchison KE. A preliminary randomized trial of the safety, tolerability, and clinical effects of hemp-derived cannabidiol in alcohol use disorder. Front Psychiatry. 2025 Apr 28;16:1516351. doi: 10.3389/fpsyt.2025.1516351. eCollection 2025.

Drugs

Indications